Name | 2-(Diethylamino)ethyl N-(2-chloro-6-methylbenzoyl)-4-[(2,6-dichlo robenzoyl)amino]-L-phenylalaninate |
---|---|
Synonyms | Valategrast (R411) |
Description | Valategrast (R-411 free base) is a potent and orally active integrin α4β1 (VLA-4) and α4β7 dual antagonist. Valategrast has the potential for Chronic obstructive pulmonary disease (COPD) and asthma treatment[1][2]. |
---|---|
Related Catalog | |
Target |
Integrin α4β1; Integrin α4β7[2] |
In Vitro | Valategrast contains a common l-phenylalanine-N-aroyl motif where the carboxylic acid is responsible for binding to the metal ion in the metal-ion-dependent adhesion site (MIDAS)[2]. |
References |
Molecular Formula | C30H32Cl3N3O4 |
---|---|
Molecular Weight | 604.95200 |
Exact Mass | 603.14600 |
PSA | 91.23000 |
LogP | 7.08140 |